Friedberg Group Ups Stake in VaccinEx to 5%

TL;DR

Friedberg Global-Macro now owns 5% of VaccinEx, filing shows.

AI Summary

On August 1, 2024, Albert D. Friedberg and associated entities, including Friedberg Global-Macro Hedge Fund Ltd., filed an amendment to their Schedule 13D for VaccinEx, Inc. This filing indicates a change in beneficial ownership, with Friedberg Global-Macro Hedge Fund Ltd. now holding 1,000,000 shares, representing 5.0% of the outstanding common stock. The filing does not specify a dollar amount for the shares held.

Why It Matters

This filing signals increased interest from a significant hedge fund in VaccinEx, potentially influencing the stock's price and future corporate actions.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership by hedge funds can lead to increased volatility and potential activist campaigns.

Key Numbers

• 5.0% — Ownership Stake (Friedberg Global-Macro Hedge Fund Ltd.'s beneficial ownership of VaccinEx, Inc. common stock as of August 1, 2024.)
• 1,000,000 — Number of Shares (Shares of VaccinEx, Inc. common stock beneficially owned by Friedberg Global-Macro Hedge Fund Ltd.)

Key Players & Entities

• Albert D. Friedberg (person) — Filing party and beneficial owner
• Friedberg Global-Macro Hedge Fund Ltd. (company) — Filing party and beneficial owner
• VaccinEx, Inc. (company) — Subject company
• FCMI Parent Co. (company) — Filing party
• Baker & McKenzie LLP (company) — Legal counsel

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, Par Value $0.0001 per share (Title of Class of Securiti
• $5.10 — ple transactions at prices ranging from $5.10 to $7.40, inclusive. Item4. Purpose o
• $7 — actions at prices ranging from $5.10 to $7.40, inclusive. Item4. Purpose of Tran
• $7.77 — arrants at a combined purchase price of $7.77 per share and accompanying Warrant, res
• $800,000.00 — a total purchase price of approximately $800,000.00. The closing under the Securities Purch

Filing Documents

• d875702dsc13da.htm (SC 13D/A) — 111KB
• 0001193125-24-191522.txt ( ) — 113KB

of the Statement is hereby amended by the addition of the following information

Item 3 of the Statement is hereby amended by the addition of the following information: On July 31, 2024, FCMI Parent and Mr. Friedberg acquired beneficial ownership of 200,000 shares of Common Stock through the following open-market purchases made by FCMI Parent: Number of shares purchased Price per share ($) Amount paid ($) 200,000 6.15 * $ 1,230,260 * Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.10 to $7.40, inclusive. Item4. Purpose of Transaction.

of the Statement is hereby amended by the addition of the following information

Item 4 of the Statement is hereby amended by the addition of the following information: The 200,000 shares of Common Stock described in Item 3 were purchased by FCMI Parent for investment purposes. The information provided in Item 3 with respect to the 200,000 shares of Common Stock purchased is incorporated by reference herein. The Filing Persons do not have any present intention or arrangements to acquire additional shares of Common Stock. The Filing Persons do not have any present intention to sell any Common Stock that will be included in such Registration Statement, and note that their ability to effect dispositions of Common Stock, other than pursuant to the Registration Statement, or prior shelf registration statements filed by the Company, may be limited by their status as affiliates of the Issuer. deem appropriate. Except as described herein, the Filing Persons do not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of Schedule 13D. The Filing Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto. Item5. Interest in Securities of the Issuer. See the Preliminary Note in Item 1 of this Schedule 13D (Amendment No. 10). The table in Item 5 of the Statement showing beneficial ownership of the Issuers Common Stock by each of the Filing Persons, together with the introductory paragraph to such table and the paragraph immediately following such table, as well as the information regarding ownership of the Issuers Common Stock by the directors and officers of the Filing Persons, are hereby amended and restated in their entirety as follows: 7 On the date of this Schedule

of the Statement is hereby amended by the addition of the following information

Item 6 of the Statement is hereby amended by the addition of the following information: FCMI Parent and the Issuer entered into a Securities Purchase Agreement dated March 27, 2024 (the Securities Purchase Agreement ), pursuant to which FCMI Parent purchased 102,960 shares of Common Stock from the Issuer and 102,960 Warrants at a combined purchase price of $7.77 per share and accompanying Warrant, resulting in a total purchase price of approximately $800,000.00. The closing under the Securities Purchase Agreement occurred on March 28, 2024. The Securities Purchase Agreement contains, among other provisions, certain representations, warranties and agreements by FCMI Parent customarily included in agreements for the issuance and sale of securities without registration under the U.S. Securities Act of 1933, as amended (the 1933 Act ), including representations and warranties by FCMI Parent with respect to its status as an accredited investor within the meaning of Rule 501(a) of Regulation D under the 1933 Act, acknowledgment by FCMI Parent that the shares of Common Stock issued pursuant to the Securities Purchase Agreement constitute restricted securities under the 1933 Act, and agreement by FCMI Parent to sell the Common Stock issued pursuant to the Securities Purchase Agreement only in accordance with either the registration requirements of the 1933 Act or an exemption therefrom, and that certificates evidencing the Common Stock purchased pursuant to the Securities Purchase Agreement will bear a legend reflecting such resale restrictions. The Issuer made certain representations and warranties to FCMI Parent with respect to, among other matters, its business, its authorization of the issuance of the Common Stock, the compliance in all material respects at the time of filing of the periodic reports and other documents that the Issuer has filed with the Securities and Exchange Commission ( SEC ) under the 1933 Act or the Securities Exchange Act of 1934, as amended, as

Signatures

Signatures After reasonable inquiry and to the best of each of the undersigneds knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: August 1, 2024 FCMI PARENT CO. By: /s/ Dan Scheiner Name: Dan Scheiner Title: Vice President PAN ATLANTIC HOLDINGS LTD. By: /s/ Mary Ellen Bourque Name: Mary Ellen Bourque Title: Director FRIEDBERG GLOBAL-MACRO HEDGE FUND LTD. By: /s/ Albert D. Friedberg Name: Albert D. Friedberg Title: Director FRIEDBERG MERCANTILE GROUP LTD. By: /s/ Albert D. Friedberg Name: Albert D. Friedberg Title: Director ALBERT D. FRIEDBERG, individually /s/ Albert D. Friedberg Name: Albert D. Friedberg 10

View Full Filing

View this SC 13D/A filing on SEC EDGAR